Catena Biosciences
Samantha E. Brady, Ph.D., currently serves as Technical Operations Lead at Catena Biosciences since November 2021. Prior to this role, Samantha held the position of Scientist at Vaxcyte from July 2020 to November 2021 and worked as a Research Associate at the University of Missouri-Columbia from June 2015 to December 2019, where successful collaborations with key opinion leaders led to three publications. With a specialization in virology and infectious diseases, Samantha earned a Ph.D. in Biochemistry from the University of Missouri-Columbia (2015-2019) and a Bachelor of Science in Chemistry with a concentration in Biochemistry from Lindenwood University (2012-2015).
Catena Biosciences
Catena Biosciences was founded in 2020 based on technology developed in the Francis and Doudna Labs at UC Berkeley. Their platform allows for the rapid coupling of proteins for the creation of novel therapeutics in autoimmune disorders, oncology, and vaccine development.